Search global stocks & ETFs...Ctrl K
Learn Mode
MED logo

MED - Medifast Inc

105


$12.48

-$0.11 (-0.874%)
At market close

$13.32

$0.84 (6.695%)
After Hours 5/15/26, 11:59 PM
Stock Unlock LogoScore

2.00/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
MED
Valuation Score
View as %

Stock Unlock Logo
Stock Unlock
$9.43$15MayJulSepNovJanMar

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Stock Profile
  • Market Cap
    $138.77M
  • Industry
    Consumer products
  • EPS (TTM)
    -$1.82
  • P/E (TTM)
    0.00
  • Div & Yield
    --
  • FCF Payout Ratio
    --
  • P/S (TTM)
    0.40
  • P/B
    0.70
  • Diluted Shares
    11.01M
  • Ex-Dividend
    --
  • Next Earnings
    08-03
  • Forward P/E
    0.00
  • Payout Ratio
    --
  • P/FCF (TTM)
    0.00
  • FCF Yield
    --
  • Earnings Yield
    -14.43%
  • 52 Week Range
2.00
Bad
Medifast Inc has seen its revenue decline by -36.31% over the past year, which means the company is losing sales/customers. However, it has more cash than liabilities meaning it could use its current cash position to be completely debt-free, if it wanted to.
Valuation Model
Key Score
5.00
Very Good
Management
4.00
Good

Growth
2.00
Bad

Profitability
1.00
Very Bad
Fin. Health
5.00
Very Good

Dividends
--
--

Analyst
4.00
Good
Insider Transactions
Explore Insider Tab
Buy
Sell
201020122014201620182020202220242026$0$15M$30M$45M$60M
Market News
Page 1 of 21
Form SCHEDULE 13G
Unknown Form Type

Filed on 2026-05-15 16:46:50


Form SCHEDULE 13G/A
Unknown Form Type

Filed on 2026-05-14 17:05:23


Form SCHEDULE 13G/A
Unknown Form Type

Filed on 2026-05-14 16:47:01


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-12 19:10:46


Form 10-Q
General form for quarterly financial reports under Section 13 or 15(d)

Filed on 2026-05-04 16:51:06


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-05-04 16:12:35


Form DEFA14A
Additional definitive proxy soliciting materials

Filed on 2026-04-30 09:24:26


Form ARS
Unknown Form Type

Filed on 2026-04-06 16:16:03


Form DEFA14A
Additional definitive proxy soliciting materials

Filed on 2026-04-06 16:08:38


Form DEF 14A
Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-04-06 16:06:33


Form 3
Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-03-27 17:55:56


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-27 17:54:41

Page 1 of 21
Revenue
Earnings
Free Cash Flow
2022202320242025-$550M$0$550M$1.10B$1.65B
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-04-25
High:
$12.60
1.0%
Avg:
$12.24
-1.9%
Low:
$12.12
-2.9%
(% change is relative to the current stock price: $12.48)
Analyst Recommendations
Go to Analyst Tab
2.33
Bad
0%
Strong Buy (0)
0%
Buy (0)
44%
Hold (4)
44%
Sell (4)
11%
Strong Sell (1)
About
Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. The company is headquartered in Baltimore, Maryland and currently employs 380 full-time employees. The firm is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. The company sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources.
  • IPO Date
    1993-12-30
  • Industry
    Consumer products
  • Total Employees
    380
  • Exchange
    New York Stock Exchange, Inc.
  • Reporting Currency
    USD
  • GICS
    Personal Care Products
  • GICS Sub
    Personal Care Products
  • GICS Sector
    Consumer Staples
  • GICS Group
    Household & Personal Products